Uterine cancer
Therapeutic area
Oncology
Rare disease
No
- Definition
- Primary or metastatic malignant neoplasm involving the uterine corpus and/or the cervix.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Uterine cancer
- Therapeutic area
- Oncology
- uterine cancer
- neoplasm of uterus
- tumor of uterus
- tumour of uterus
- uterine tumor
- uterine tumour
- uterus neoplasm
- cancer of the uterus
- cancer of uterus
- malignant neoplasm of the uterus
- malignant neoplasm of uterus
- malignant tumor of the uterus
- malignant tumor of uterus
- malignant tumour of the uterus
- malignant tumour of uterus
- malignant uterine neoplasm
- malignant uterine tumor
- malignant uterine tumour
- malignant uterus neoplasm
- uterine cancer
- uterus cancer
- Severity
- Severe
- Oncology
- Reproductive Health
- MONDO ID
- MONDO:0002715
- Parent condition
- MONDO:0001416
Related records
Broader conditions (16)
- Cancer
- Cancer or benign tumor
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Female reproductive organ cancer
- Female reproductive system disorder
- Female reproductive system neoplasm
- Human disease
- Neoplasm
- Neoplastic disease or syndrome
- Reproductive system cancer
- Reproductive system disorder
- Reproductive system neoplasm
- Tumor of uterus
- Uterine disorder
Narrower conditions (106)
- Adenoid cystic carcinoma of the corpus uteri
- Broad ligament malignant neoplasm
- Carcinosarcoma of the corpus uteri
- Cervical adenocarcinoma
- Cervical adenoid basal carcinoma
- Cervical adenoid cystic carcinoma
- Cervical adenosarcoma
- Cervical adenosquamous carcinoma
- Cervical adenosquamous carcinoma, glassy cell variant
- Cervical alveolar soft part sarcoma
- Cervical basaloid carcinoma
- Cervical cancer
- Cervical carcinoma
- Cervical carcinosarcoma
- Cervical clear cell adenocarcinoma
- Cervical endometrioid adenocarcinoma
- Cervical keratinizing squamous cell carcinoma
- Cervical large cell neuroendocrine carcinoma
- Cervical lymphoepithelioma-like carcinoma
- Cervical mucinous adenocarcinoma
Trials (154)
- [18F]FES PET/.CT in Uterine Cancer
- A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
- A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors
- A Mind-body Intervention to Improve Body and/or Self Image
- A Phase II Study of Paclitaxel and Carboplatin in Patients With an Elevated-Risk Cancer of the Uterus
- A Phase II Study of Therapy With Paclitaxel, Carboplatin and Megesterol Acetate for the Management of Uterine Cancer
- A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers
- A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors
- A Retrospective Study on Multiple Classifier Endometrial Cancer
- A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping
- A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma
- A Study of Nivolumab in Selected Uterine Cancer Patients
- A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma
- A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
- A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors
- A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies
- A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers
- Adherence and Compliance to ERAS in Gynecological Surgery
- Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma
- Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus
Drugs in development (16)
- Adavosertib Phase 2
- Batiraxcept Phase 1
- Bevacizumab Phase 2
- Carboplatin Phase 3
- Celecoxib Phase 2
- Cisplatin Phase 3
- Everolimus Phase 2
- Fluoroestradiol Phase 2
- Ifosfamide Phase 2
- Imatinib mesylate Phase 1
- Letrozole Phase 2
- Megestrol acetate Phase 2
- Olaparib Phase 1
- Paclitaxel Phase 3
- Pembrolizumab Phase 1
- Proflavine Phase 2